CA2060825A1 - Agent therapeutique - Google Patents
Agent therapeutiqueInfo
- Publication number
- CA2060825A1 CA2060825A1 CA002060825A CA2060825A CA2060825A1 CA 2060825 A1 CA2060825 A1 CA 2060825A1 CA 002060825 A CA002060825 A CA 002060825A CA 2060825 A CA2060825 A CA 2060825A CA 2060825 A1 CA2060825 A1 CA 2060825A1
- Authority
- CA
- Canada
- Prior art keywords
- compound
- ethyl
- biphenyl
- tetrazol
- methoxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB919102727A GB9102727D0 (en) | 1991-02-08 | 1991-02-08 | Pharmaceutical agent |
| GB9102727.6 | 1991-02-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2060825A1 true CA2060825A1 (fr) | 1992-08-09 |
Family
ID=10689748
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002060825A Abandoned CA2060825A1 (fr) | 1991-02-08 | 1992-02-07 | Agent therapeutique |
Country Status (12)
| Country | Link |
|---|---|
| CN (1) | CN1064809A (fr) |
| AP (1) | AP9200355A0 (fr) |
| AU (1) | AU1189392A (fr) |
| CA (1) | CA2060825A1 (fr) |
| GB (2) | GB9102727D0 (fr) |
| HU (1) | HUT60489A (fr) |
| IE (1) | IE920243A1 (fr) |
| IL (1) | IL100793A0 (fr) |
| MX (1) | MX9200532A (fr) |
| PT (1) | PT100097A (fr) |
| WO (1) | WO1992013853A1 (fr) |
| ZA (1) | ZA92729B (fr) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW297025B (fr) * | 1992-02-14 | 1997-02-01 | Squibb & Sons Inc | |
| US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
| JP5546451B2 (ja) | 2007-06-04 | 2014-07-09 | シナジー ファーマシューティカルズ インコーポレイテッド | 胃腸の障害、炎症、癌および他の障害の処置に有用なグアニル酸シクラーゼのアゴニスト |
| US20100120694A1 (en) | 2008-06-04 | 2010-05-13 | Synergy Pharmaceuticals, Inc. | Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders |
| EP3241839B1 (fr) | 2008-07-16 | 2019-09-04 | Bausch Health Ireland Limited | Agonistes de guanylate cyclase utiles pour le traitement de troubles gastro-intestinaux, inflammatoires, cancéreux et autres |
| US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
| AU2014235209B2 (en) | 2013-03-15 | 2018-06-14 | Bausch Health Ireland Limited | Guanylate cyclase receptor agonists combined with other drugs |
| HK1220696A1 (zh) | 2013-03-15 | 2017-05-12 | Bausch Health Ireland Limited | 鸟苷酸环化酶激动剂及其用途 |
| EP4424697A3 (fr) | 2013-06-05 | 2024-12-25 | Bausch Health Ireland Limited | Agonistes ultra-purs de guanylate cyclase c, leur procédé de fabrication et d'utilisation |
| ES2784423T3 (es) | 2013-09-16 | 2020-09-25 | Astrazeneca Ab | Nanopartículas poliméricas terapéuticas y métodos para su fabricación y uso |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4920132A (en) * | 1987-11-03 | 1990-04-24 | Rorer Pharmaceutical Corp. | Quinoline derivatives and use thereof as antagonists of leukotriene D4 |
| ATE117294T1 (de) * | 1989-08-11 | 1995-02-15 | Ici Plc | Chinolin-derivate, verfahren zu ihrer herstellung und ihre anwendung als arzneimittel. |
-
1991
- 1991-02-08 GB GB919102727A patent/GB9102727D0/en active Pending
-
1992
- 1992-01-27 IE IE024392A patent/IE920243A1/en unknown
- 1992-01-28 IL IL100793A patent/IL100793A0/xx unknown
- 1992-01-31 ZA ZA92729A patent/ZA92729B/xx unknown
- 1992-02-03 AP APAP/P/1992/000355A patent/AP9200355A0/en unknown
- 1992-02-05 AU AU11893/92A patent/AU1189392A/en not_active Abandoned
- 1992-02-05 WO PCT/GB1992/000214 patent/WO1992013853A1/fr not_active Ceased
- 1992-02-05 GB GB9202377A patent/GB2252557A/en not_active Withdrawn
- 1992-02-05 HU HU9200354A patent/HUT60489A/hu unknown
- 1992-02-06 PT PT100097A patent/PT100097A/pt not_active Application Discontinuation
- 1992-02-07 MX MX9200532A patent/MX9200532A/es unknown
- 1992-02-07 CA CA002060825A patent/CA2060825A1/fr not_active Abandoned
- 1992-02-08 CN CN92101425A patent/CN1064809A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| HUT60489A (en) | 1992-09-28 |
| GB9102727D0 (en) | 1991-03-27 |
| GB2252557A (en) | 1992-08-12 |
| AU1189392A (en) | 1992-09-07 |
| PT100097A (pt) | 1993-04-30 |
| ZA92729B (en) | 1992-11-25 |
| WO1992013853A1 (fr) | 1992-08-20 |
| IL100793A0 (en) | 1992-09-06 |
| CN1064809A (zh) | 1992-09-30 |
| IE920243A1 (en) | 1992-08-12 |
| MX9200532A (es) | 1992-08-01 |
| GB9202377D0 (en) | 1992-03-18 |
| HU9200354D0 (en) | 1992-04-28 |
| AP9200355A0 (en) | 1993-08-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101221864B1 (ko) | 4-［［(7ｒ)-8-사이클로펜틸-7-에틸-5,6,7,8-테트라하이드로-5-메틸-6-옥소-2-프테리디닐］아미노］-3-메톡시-ｎ-(1-메틸-4-피페리디닐)벤즈아미드의 수화물 및 다형체, 이들의 제조방법, 및 약제로서의 이들의 용도 | |
| CA2141692C (fr) | Promedicaments d'acides carboxyles d'imidazole comme antagonistes des recepteurs de l'angiotensine ii | |
| CZ398191A3 (en) | Novel 4-amino alkyl-2(3h)-indolones and pharmaceutical compositions containing them | |
| US20020016351A1 (en) | New crystals of celecoxib | |
| EP0507696A1 (fr) | Antihistaminiques non sédatifs, dérivés de benzimidazole, leur procédé de préparation et leur utilisation en tant que médicaments. | |
| CA2060825A1 (fr) | Agent therapeutique | |
| SK46793A3 (en) | Regenarative melting tank and method of working | |
| US7504516B2 (en) | Crystalline forms of candesartan cilexetil | |
| NZ209912A (en) | Imidazoline derivatives and pharmaceutical compositions | |
| IE912406A1 (en) | Process | |
| JP4662979B2 (ja) | 新規なβ−アゴニスト、その製造方法及びその薬物としての使用 | |
| WO1989005799A1 (fr) | Nouveaus derives de tetrahydropyridine, compositions pharmaceutiques contenant ces derives et procede de preparation de ces derives | |
| CA1330663C (fr) | Derives thiazolidinedione | |
| JP2002528541A (ja) | Ｔｎｆおよびｐｄｅ−ｉｖ阻害活性を有する複素環式化合物のｎ−オキシド | |
| JP3588363B2 (ja) | キノキサリンジオン類 | |
| MXPA03005884A (es) | Hemimaleato de amlodipina. | |
| WO1988001270A1 (fr) | Pyridopyrimidinediones | |
| IE46821B1 (en) | 3,5-disubstituted-1h-1,2,4-triazoles | |
| EP0906309A1 (fr) | Forme modifiee de l'hydrochlorure de l'acide r(-)-n-(4,4-di(3-methylthien-2-yl)but-3-enyl)-nipecotique | |
| IE44184B1 (en) | Imidazole derivatives,processes for their preparation and pharmaceutical compositions containing them | |
| US4081551A (en) | Oxime ethers having anti-depressive activity | |
| WO2004076443A1 (fr) | Forme amorphe de potassium de losartan | |
| TWI221152B (en) | Method for preparing sodium-hydrogen exchanger type 1 inhibitor | |
| EP0170549B1 (fr) | Dérivés de tétrahydro-4,5,6,7 furo ou 1H-pyrrolo[2,3-c]pyridine, leur préparation et leur application en therapeutique | |
| EP0277805A1 (fr) | Hétérocycles ergoliniques |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued |